The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity
- PMID: 11191109
- PMCID: PMC1507985
- DOI: 10.1038/sj.neo.7900112
The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity
Abstract
The telomerase catalytic subunit (hTERT) is an essential component of the holoenzyme complex that adds telomeric repeats to the ends of human chromosomes. Maintenance of telomeres by telomerase or another mechanism is required for cell immortalization, and loss of telomeric DNA has been proposed as a trigger for cellular senescence. Available evidence suggests that regulation of telomerase activity primarily depends on transcriptional control of hTERT. However, several human tissues as well as some normal cell strains have been shown to express low levels of hTERT mRNA even though they lack telomerase activity. We have previously identified six splice variants of hTERT, including a "deletion" variant (hTERTalpha) that is missing conserved residues from the catalytic core of the protein. Several of the deletion variants have been detected in normal and developing human tissues. We now show that hTERTalpha inhibits endogenous telomerase activity, which results in telomere shortening and chromosome end-to-end fusions. Telomerase inhibition induced a senescence-like state in HT1080 cells and apoptosis in a jejunal fibroblast cell line. These results suggest a possible role for hTERT splice variants in the regulation of telomerase activity.
Figures




Similar articles
-
An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity.Neoplasia. 2000 Sep-Oct;2(5):433-40. doi: 10.1038/sj.neo.7900113. Neoplasia. 2000. PMID: 11191110 Free PMC article.
-
Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.Oncogene. 1999 Jul 22;18(29):4211-23. doi: 10.1038/sj.onc.1202797. Oncogene. 1999. PMID: 10435634
-
Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit.Oncogene. 2002 Jan 3;21(1):128-39. doi: 10.1038/sj.onc.1205014. Oncogene. 2002. PMID: 11791183
-
Telomeres, telomerase, and myc. An update.Mutat Res. 2000 Jan;462(1):31-47. doi: 10.1016/s1383-5742(99)00091-5. Mutat Res. 2000. PMID: 10648922 Review.
-
Telomere length maintenance in aging and carcinogenesis.Int J Oncol. 2000 Nov;17(5):981-9. doi: 10.3892/ijo.17.5.981. Int J Oncol. 2000. PMID: 11029502 Review.
Cited by
-
Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.Front Endocrinol (Lausanne). 2020 Jul 31;11:485. doi: 10.3389/fendo.2020.00485. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32849278 Free PMC article. Review.
-
Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation.Mol Cell Biol. 2012 Nov;32(21):4283-96. doi: 10.1128/MCB.00550-12. Epub 2012 Aug 20. Mol Cell Biol. 2012. PMID: 22907755 Free PMC article.
-
Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.Mol Cell Biol. 2001 Jun;21(12):3862-75. doi: 10.1128/MCB.21.12.3862-3875.2001. Mol Cell Biol. 2001. PMID: 11359895 Free PMC article.
-
RESISTIN EFFECT ON TELOMERASE GENE EXPRESSION IN GASTRIC CANCER CELL LINE AGS.Acta Endocrinol (Buchar). 2016 Apr-Jun;12(2):145-149. doi: 10.4183/aeb.2016.145. Acta Endocrinol (Buchar). 2016. PMID: 31149079 Free PMC article.
-
Molecular regulation of telomerase activity in aging.Protein Cell. 2011 Sep;2(9):726-38. doi: 10.1007/s13238-011-1093-3. Epub 2011 Oct 6. Protein Cell. 2011. PMID: 21976062 Free PMC article. Review.
References
-
- Colgin LM, Reddel RR. Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev. 1999;9:97–103. - PubMed
-
- Olovnikov AM. Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSR. 1971;201:1496–1499. - PubMed
-
- Harley CB. Telomere loss: Mitotic clock or genetic time bomb? Mutat Res. 1991;256:271–282. - PubMed
-
- Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 1996;56:645–650. - PubMed
-
- Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Amgen EST Program. Bass MB, Arruda I, Robinson MO. A mammalian telomerase-associated protein. Science. 1997;275:973–977. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources